Clinical trial
Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
NCT01237028 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- August 31, 2016
- Enrollment
- 168 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
iga nephropathy